Ratings
0
Nobody has rated this yet. Be the first!
Works
6
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
